Horii Ikuo | Drug Safety Evaluation Global Research & Development Pfizer Inc.
スポンサーリンク
概要
関連著者
-
Horii Ikuo
Drug Safety Evaluation Pfizer Global Research And Development
-
Horii Ikuo
Drug Safety Evaluation Global Research & Development Pfizer Inc.
-
HORII IKUO
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
Horii Ikuo
Showa Univ. (department Of Biochemical Toxicology School Of Pharmaceutical Sciences)
-
Horii I
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Horii Ikuo
Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
HAMADA Yoshimasa
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc.
-
Yamada Hiroshi
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Yamada Hiroshi
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Hamada Yoshimasa
Drug Safety Research And Development Nagoya Laboratories Pfizer Japan Inc.
-
SHIRAI NORIMITSU
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
IIDAKA TAKESHI
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
Yamamoto Toshinori
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
FUKUSHIMA Tamio
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc.
-
YAMADA Hiroshi
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc.
-
Fukushima Tamio
Drug Safety Research And Development Nagoya Laboratories Pfizer Japan Inc.
-
Fukushima Tamio
Pfizer Global Research & Development Toxicology Nagoya Laboratoreis
-
Yamamoto Toshinori
Drug Metabolism Laboratory Chugai Pharmaceutical Co. Ltd.
-
Fukushima Tamio
Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
今井 敏夫
Drug Safety & Disposition Research Laboratories Eisai Co. Ltd.
-
高橋 通正
(独)産業技術総合研究所 環境管理技術研究部門
-
Tatematsu M
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Tsukamoto T
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
TSUKAMOTO Tetsuya
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
TATEMATSU Masae
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
IIDAKA Takeshi
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
SHIRAI Norimitsu
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
Iidaka Takeshi
ファイザー 中央研究所
-
Iidaka Takeshi
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Iidaka Takeshi
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究統括部
-
Iidaka Takeshi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究
-
YOSHIDA Takemi
Department of Biochemical Toxicology, School of Pharmacy, Showa University
-
Yamamoto T
Showa Univ. Tokyo Jpn
-
Yamamoto Toshinori
Department Of Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
Tatematsu Masae
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
TOMIZAWA Kaori
Drug Safety Research & Development, Pfizer Global Research & Development, Nagoya Laboratories
-
FUJIKAWA Masaaki
Drug Safety Research & Development, Pfizer Global Research & Development, Nagoya Laboratories
-
SATO Yasushi
Drug Safety Research & Development, Pfizer Global Research & Development, Nagoya Laboratories
-
KIKKAWA Rie
Drug Safety Research & Development, Nagoya Laboratories, Pfizer Japan Inc.
-
Tatematsu M
愛知県がんセンター研究所 腫瘍病理学部
-
Tsukamoto Tetsuya
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Kikkawa Rie
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Inc.
-
Kikkawa Rie
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Worldwide Safety Sciences Nagoya Laboratories Pfizer Global Research And Development Pfizer Japan In
-
Horii Ikuo
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Inoue Tomoaki
Department Of Preclinical Science Nippon Roche Research Center
-
Kurata Masaaki
ファイザー製薬中央研究所 安全性研究統括部
-
Kurata Masaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Tomizawa Kaori
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Yoshida Takemi
Department Of Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
高岡 雅哉
Medicinal Safety Research Laboratories Daiichi-sankyo Co. Ltd.
-
Tatematsu Masae
愛知県がんセンター研究所 腫瘍病理学部
-
Yoshida Takemi
Department Of Biochemical Toxicology School Of Pharmaceutical Science Showa University
-
Imai Toshio
Laboratory Of Pathology Aichi Cancer Center Research Institute
-
Tajika Masahiro
Department Of Gastroenterology Aichi Cancer Center Hospital
-
Takaoka Masaya
Medicinal Safety Research Laboratories Daiichi-sankyo Co. Ltd.
-
Kikkawa Rie
Pfizer Global Research & Development Toxicology Nagoya Laboratoreis
-
Makino Toshihiko
Medicinal Safety Research Laboratories Daiichi Sankyo Co. Ltd.:department Of Veterinary Pathology Gr
-
Shirai Norimitsu
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Fujikawa Masaaki
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Fujikawa Masaaki
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Japan
-
Yamamoto Toshinori
Departments Of Clinical Pharmacy And Pharmacognosy School Of Pharmaceutical Sciences Showa Universit
-
Yamamoto Toshinori
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Tsukamoto Takahisa
First Department Of Oral And Maxillofacial Surgery School Of Dentistry
-
Mizoshita Tsutomu
Department Of Gastroenterology And Metabolism Nagoya City University Graduate School Of Medical Scie
-
Tsukamoto Takahisa
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Taniyama Tetsuhide
First Department Of Oral And Maxillofacial Surgery School Of Dentistry
-
Nii Aisuke
Drug Safety Research And Development Pfizer Global Research & Development Nagoya Laboratories
-
Nii Aisuke
Drug Safety Research & Development Nagoya Laboratories Pfizer Global Research And Development
-
Shirai Norimitsu
Drug Safety Research And Development Pfizer Global Research & Development Nagoya Laboratories
-
Tsukamoto T
Department Of Public Health Osaka City University Graduate School Of Medicine
-
Horii Ikuo
Drug Safety Research And Development Pfizer Global Research & Development Nagoya Laboratories
-
Hamada Y.
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Inoue Tomoaki
Department Of Applied Molecular Chemistry College Of Industrial Technology Nihon University
-
Fujikawa Masaaki
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Japan
-
Sato Yasushi
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Yamamoto Toshinori
Department Of Pharmacology Medical College Of Oita
-
Makita Takashi
Dept. Vet. Anat. Yamaguchi Univ.
-
Makita Takashi
Medicinal Safety Research Laboratories Daiichi Sankyo Co. Ltd.:department Of Veterinary Pathology Gr
-
Kurata Masaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Imai T
Human Genome Ctr.
-
Sato Yasushi
Drug Safety And Pharmacokinetics Laboratories Taisho Pharmaceutical Co. Ltd.
-
Inoue Tomoaki
Department of Preclinical Science, Nippon Roche Research Center
著作論文
- Tissue-dependent susceptibility of p53 knockout mice to chemical-induced carcinogenesis (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- CHANGES OF MICRO-RNA EXPRESSION IN RAT LIVER TREATED BY ACETAMINOPHEN OR CARBON TETRACHLORIDE : REGULATING ROLE OF MICRO-RNA FOR RNA EXPRESSION
- EVALUATION OF HUMAN HEPATOCYTE CHIMERIC MICE AS A MODEL FOR TOXICOLOGICAL INVESTIGATION USING PANOMIC APPROACHES : EFFECT OF ACETAMINOPHEN ON THE EXPRESSION PROFILES OF PROTEINS AND ENDOGENOUS METABOLITES IN LIVER, PLASMA AND URINE
- GENOMIC CLUSTER AND NETWORK ANALYSIS FOR PREDICTIVE SCREENING FOR HEPATOTOXICITY
- SIMULTANEOUS MEASUREMENT OF NUCLEATED CELL COUNTS AND CELLULAR DIFFERENTIALS IN RAT BONE MARROW EXAMINATION USING FLOW CYTOMETER
- INTEGRATED NMR-BASED METABONOMIC INVESTIGATION OF EARLY METABOLIC EFFECTS OF ETHYLENE GLYCOL MONOMETHYL ETHER (EGME) ON MALE REPRODUCTIVE ORGANS IN RATS
- Neuronal Necrosis in a Dog Following Exposure to an NMDA Receptor Antagonist
- Development of an Antigenicity Study Consisting of in vitro Priming in Mouse Peritoneal Exudate Cells and in vitro Anaphylaxis Test in Rat Mast Cells
- Current Status and Future Aspects of Toxicologically Responsible Biomarkers (SYMPOSIUM2: CURRENT STATUS AND FUTURE ASPECTS OF TOXICOLOGICALLY RESPONSIBLE BIOMARKERS) (Proceedings of the 30th Annual Meeting)